1355.HK HKSE
Biosysen Limited
1W: +0.0%
1M: +35.2%
3M: +35.2%
YTD: +45.2%
1Y: +42.0%
3Y: -7.1%
5Y: -39.7%
HK$0.20 ($0.02)
-0.02 (-9.26%)
Weekly Expected Move ±23.7%
HK$0
HK$0
HK$0
HK$0
HK$0
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
Balance Sheet Trends
Total Assets
$75M
-41.1% ▼
5Y CAGR: +1.0%
Total Liabilities
$180M
-14.1% ▼
5Y CAGR: +21.7%
Shareholders Equity
-$42M
-16.5% ▼
Cash & Investments
$14M
+225.1% ▲
5Y CAGR: +4.3%
Total Debt
$165M
-9.1% ▼
5Y CAGR: +22.5%
Net Debt
$151M
-15.7% ▼
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $20M | $14M | $2M | $2M | $14M |
| Short-Term Investments | $0 | $3M | $4M | $2M | $0 |
| Cash & ST Investments | $20M | $17M | $6M | $4M | $14M |
| Net Receivables | $548K | $5M | $16M | $1M | $965K |
| Inventory | $110K | $379K | $344K | $384K | $402K |
| Other Current Assets | $239K | $3M | $3M | $3M | $2M |
| Total Current Assets | $24M | $26M | $29M | $9M | $18M |
| Property, Plant & Equip. | $200M | $205M | $159M | $112M | $54M |
| Goodwill & Intangibles | $2M | $2M | $2M | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 | $0 |
| Other Non-Current Assets | $3M | $5M | $2M | $3M | $3M |
| Total Non-Current Assets | $207M | $214M | $167M | $118M | $57M |
| Total Assets | $232M | $240M | $196M | $127M | $75M |
| — Liabilities — | |||||
| Accounts Payable | $108K | $2M | $992K | $2M | $2M |
| Short-Term Debt | $37M | $23M | $27M | $27M | $29M |
| Deferred Revenue | $0 | $0 | $0 | $0 | $0 |
| Other Current Liabilities | $11M | $31M | $30M | $16M | $4M |
| Total Current Liabilities | $82M | $86M | $91M | $81M | $73M |
| Long-Term Debt | $0 | $0 | $0 | $0 | $0 |
| Other Non-Current Liab. | $444K | $480K | $463K | $477K | $482K |
| Total Non-Current Liabilities | $148M | $156M | $126M | $129M | $107M |
| Total Liabilities | $229M | $242M | $217M | $210M | $180M |
| — Equity — | |||||
| Common Stock | $4M | $4M | $4M | $4M | $5M |
| Retained Earnings | -$271M | -$268M | -$276M | -$314M | -$331M |
| Accumulated OCI | $12M | $14M | $12M | $8M | -$48M |
| Total Stockholders Equity | $7M | $12M | $2M | -$36M | -$42M |
| Total Liabilities & Equity | $232M | $240M | $196M | $127M | $75M |
| — Key Metrics — | |||||
| Total Debt | $215M | $204M | $176M | $182M | $165M |
| Net Debt | $195M | $189M | $173M | $179M | $151M |
| Total Investments | $0 | $3M | $4M | $2M | $0 |